Canada Pension Plan Investment Board’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,600
Closed -$303K 1874
2025
Q4
$303K Sell
1,600
-1,900
-54% -$365K ﹤0.01% 1516
2025
Q3
$620K Sell
3,500
-500
-13% -$74.3K ﹤0.01% 1030
2025
Q2
$455K Buy
+4,000
New +$428K ﹤0.01% 1031
2021
Q1
Sell
-7,507
Closed -$466K 1424
2020
Q4
$466K Buy
+7,507
New +$428K ﹤0.01% 1153
2020
Q3
Sell
-26
Closed -$2K 1238
2020
Q2
$2K Sell
26
-6,630
-100% -$420K ﹤0.01% 1363
2020
Q1
$302K Buy
6,656
+1,740
+35% +$98.6K ﹤0.01% 1063
2019
Q4
$320K Buy
+4,916
New +$329K ﹤0.01% 1213
2019
Q2
Sell
-59,311
Closed -$4.65M 1373
2019
Q1
$4.65M Sell
59,311
-82,074
-58% -$6.22M 0.01% 809
2018
Q4
$12M Buy
141,385
+82,715
+141% +$8.82M 0.03% 510
2018
Q3
$10M Buy
+58,670
New +$8.85M 0.02% 611
2016
Q4
Sell
-36,548
Closed -$2.33M 1127
2016
Q3
$2.33M Sell
36,548
-21,641
-37% -$1.59M 0.01% 673
2016
Q2
$4.33M Sell
58,189
-10,580
-15% -$785K 0.02% 561
2016
Q1
$4.59M Buy
68,769
+6,092
+10% +$370K 0.02% 563
2015
Q4
$4.24M Buy
62,677
+16,991
+37% +$1.05M 0.02% 566
2015
Q3
$2.44M Buy
+45,686
New +$2.77M 0.01% 708
2014
Q2
Sell
-481
Closed -$20K 1268
2014
Q1
$20K Buy
+481
New +$20K ﹤0.01% 1234

Other funds holding LGND

Canada Pension Plan Investment Board's LGND Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Ligand Pharmaceuticals (LGND) in Q1 2026, closing a stake of 1,600 shares — an estimated $303K sold.

Canada Pension Plan Investment Board first reported a position in LGND in Q1 2014 and held it in 16 quarters. The position peaked at $12M in Q4 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Canada Pension Plan Investment Board reported no remaining Ligand Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 1,600 Ligand Pharmaceuticals shares in Q1 2026, an estimated $303K.
  • Canada Pension Plan Investment Board first reported a position in Ligand Pharmaceuticals in Q1 2014 and held it in 16 quarters.
  • Canada Pension Plan Investment Board's Ligand Pharmaceuticals position peaked at $12M in Q4 2018.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.